Literature DB >> 4338122

Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.

P C Harpel.   

Abstract

This study has demonstrated that collagen particles, after exposure to platelet-poor human plasma and subsequent washing, generate a kinin-like agent when incubated with prekinin substrate. The binding of kinin-generating activity to collagen in the plasma collagen incubation mixture occurs rapidly, whereas the loss of this activity in the incubation mixture occurs relatively slowly. The Hageman factor appeared to be necessary for the surface-bound kinin-generating activity, as this activity was absent in collagen exposed to Hageman factor-deficient plasma. These studies have partially characterized the plasma-derived enzymatic activity bound to collagen. Incubation of collagen with plasma caused a concentration-dependent reduction in the kinin-producing activity which was generated by the addition of ellagic acid, a known activator of plasma kallikrein. The kinin-inducing activity bound to collagen is inhibited by soybean trypsin inhibitor, Trasylol, serum C1 inactivator and the plasma alpha(2)-macroglobulin, but not by lima bean trypsin inhibitor. An eluate prepared from plasma-treated collagen, when compared with purified plasma kallikrein, shared a similar inhibitor profile. Selective chemical blockage of the free carboxyl groups on the collagen molecule, or heat denaturation, inactivated the ability of the collagen to generate kinin-like activity after incubation with plasma. Removal of the collagen telopeptides or blockage of the free amino groups failed to affect the collagen-plasma interaction. The binding of partially purified plasma kallikrein to collagen was found to have similar structural and chemical requirements. These data indicate that there is a structural and chemical specificity for the activation and binding of plasma kallikrein-like activity by collagen. These studies suggest that a plasma kallikrein may function as a surface-bound enzyme system.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338122      PMCID: PMC292329          DOI: 10.1172/jci106983

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

2.  Action of the kallikreins on synthetic ester substrates.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

3.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. V. Activable permeability factor in human serum.

Authors:  J M ELDER; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1958-08

4.  Effect of inhibitors on kinin-releasing activity of proteases.

Authors:  N Back; R Steger
Journal:  Fed Proc       Date:  1968 Jan-Feb

5.  Aggregation of platelets by collagen.

Authors:  G D Wilner; H L Nossel; E C LeRoy
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

Review 6.  The biology and pathology of the initial stages of blood coagulation.

Authors:  O D Ratnoff
Journal:  Prog Hematol       Date:  1966

7.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

Authors:  C D Forbes; J Pensky; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1970-11

8.  Adsorption of Hageman factor (Factor XII) on collagen.

Authors:  S Niewiarowski; E Bańkowski; T Fiedoruk
Journal:  Experientia       Date:  1964-07-15

9.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  10 in total

1.  Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

Authors:  P C Harpel; M W Mosesson
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

Review 2.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

3.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.

Authors:  R C Wiggins; B N Bouma; C G Cochrane; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage.

Authors:  H Kasuya; T Shimizu; T Okada; K Takahashi; T Summerville; K Kitamura
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

5.  High molecular weight kininogen binds to unstimulated platelets.

Authors:  E J Gustafson; D Schutsky; L C Knight; A H Schmaier
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

6.  Modulation of C1-Inhibitor and Plasma Kallikrein Activities by Type IV Collagen.

Authors:  Sriram Ravindran; Marc Schapira; Philip A Patston
Journal:  Int J Biomater       Date:  2012-02-12

7.  Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.

Authors:  Allen Clermont; Tamie J Chilcote; Takeshi Kita; Jia Liu; Priscilla Riva; Sukanto Sinha; Edward P Feener
Journal:  Diabetes       Date:  2011-03-28       Impact factor: 9.461

8.  Activation of factor XII by tobacco glycoprotein.

Authors:  C G Becker; T Dubin
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

Review 9.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

10.  Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.